Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV13... Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 2.5 | 2.5 | 2.5 | 0 | 0 | CS |
| 4 | 0 | 0 | 2.5 | 2.5 | 2.5 | 0 | 0 | CS |
| 12 | 0 | 0 | 2.5 | 2.5 | 2.5 | 0 | 0 | CS |
| 26 | -1.57 | -38.5749385749 | 4.07 | 7.85 | 2.3577 | 15411 | 5.62542123 | CS |
| 52 | -12 | -82.7586206897 | 14.5 | 15.4625 | 2.3577 | 297305 | 6.67136901 | CS |
| 156 | -294.6875 | -99.1587802313 | 297.1875 | 381.9375 | 2.3577 | 750749 | 109.97056631 | CS |
| 260 | -541.25 | -99.5402298851 | 543.75 | 2812.5 | 2.3577 | 1881000 | 995.39964148 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
